Tech Company Financing Transactions

Airna Funding Round

On 4/1/2025, Airna raised $155 million in Series B funding from Forbion Growth Opportunities Fund II, Venrock Healthcare Capital Partners and Arch Venture Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

238 Main Street c/o Bayer Co.Lab
Cambridge, MA 02142
USA

Phone

Undisclosed

Website

www.airna.com

Email Address

[email protected]

Overview

AIRNA is on a mission to transform the lives of patients with rare and common diseases by pioneering the discovery and development of RNA editing therapeutics. AIRNA's powerful and flexible RNA editing platform, RESTORE+�, is designed to restore a patient's health by creating genetic medicines for rare and common diseases. RESTORE+� is a systematic advancement of the first published ADAR platform developed by AIRNA's founders, created to maximize therapeutic properties and address novel targets.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kris Elverum

        

Browse more venture capital transactions:

Prev: 4/1/2025: Focused Energy venture capital transaction
Next: 4/1/2025: Notable Systems venture capital transaction

Share this article

Where The Data Comes From

We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary